Nucleome Therapeutics: Decoding the Regulatory Genome

Описание: In the vast landscape of human genetics, only 2-3% of our DNA directly codes for proteins—the building blocks of life. The remaining 97-98% was once dismissed as "junk DNA" but is now understood to be crucial regulatory code that controls how, when, and where genes are expressed.  

Oxford University spin-out Nucleome Therapeutics is pioneering a revolutionary approach to decode this regulatory genome, with profound implications for how we understand and treat human diseases. Their platform, which combines sophisticated machine learning with next-generation sequencing technology, is already yielding promising drug candidates for autoimmune conditions like rheumatoid arthritis and lupus.